← FDA Drug Approvals (Drugs@FDA)

POSFREA

NDA · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2016-03-01

Drug application

FDA Application #

NDA203050

Application type

New Drug Application

Brand name

POSFREA

Generic name

PALONOSETRON

Active ingredients

PALONOSETRON HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

AVYXA HOLDINGS

Manufacturer

Avyxa Pharma, LLC

First approval

2016-03-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown